Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Enprofylline (Enprofilina), a bronchodilator, acts primarily as a competitive nonselective phosphodiesterase inhibitor. Enprofylline is used in asthma, chronic obstructive pulmonary disease, and in the management of sickle cell disease, diabetic neuropathy, and cerebrovascular insufficiency.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 43.00 | |
2 mg | In stock | $ 61.00 | |
5 mg | In stock | $ 98.00 | |
10 mg | In stock | $ 141.00 | |
25 mg | In stock | $ 253.00 | |
50 mg | In stock | $ 397.00 | |
100 mg | In stock | $ 588.00 | |
500 mg | In stock | $ 1,260.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 95.00 |
Description | Enprofylline (Enprofilina), a bronchodilator, acts primarily as a competitive nonselective phosphodiesterase inhibitor. Enprofylline is used in asthma, chronic obstructive pulmonary disease, and in the management of sickle cell disease, diabetic neuropathy, and cerebrovascular insufficiency. |
Targets&IC50 | A2B receptor:7 μM (Ki) |
Synonyms | Enprofilina, 3-propylxanthine, 3-n-Propylxanthine, Enprofyllinum |
Molecular Weight | 194.19 |
Formula | C8H10N4O2 |
CAS No. | 41078-02-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: Insoluble
DMSO: 60 mg/ml (308.98 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Enprofylline 41078-02-8 Others Enprofilina chronic obstructive pulmonary interleukin-8 A2B receptor antagonist phosphodiesterase inhibitor Adenosine Receptor 3-propylxanthine Adenosine inhibit asthma Inhibitor phospholipase C P1 receptor Phosphodiesterase (PDE) 3-n-Propylxanthine Enprofyllinum inhibitor